{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:04:55Z","timestamp":1772820295576,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T00:00:00Z","timestamp":1220486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T00:00:00Z","timestamp":1220486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/leu.2008.219","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T09:52:20Z","timestamp":1220521940000},"page":"1849-1852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?"],"prefix":"10.1038","volume":"22","author":[{"given":"F J T","family":"Staal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Pike-Overzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y Y","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J M","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,4]]},"reference":[{"key":"BFleu2008219_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","volume":"348","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255\u2013256.","journal-title":"N Engl J Med"},{"key":"BFleu2008219_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415\u2013419.","journal-title":"Science"},{"issue":"9","key":"BFleu2008219_CR3","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1172\/JCI35798","volume":"118","author":"Steven J. Howe","year":"2008","unstructured":"Howe S, Mansour M, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis in combination with acquired somatic mutations leads to leukemogenesis following gene therapy of SCID-X1. J Clin Invest 2008, doi:10.1172\/JCI35798.","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"BFleu2008219_CR4","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"Salima Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest, doi:10.1172\/JCI35700.","journal-title":"Journal of Clinical Investigation"},{"key":"BFleu2008219_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymthe.2003.10.013","volume":"9","author":"C Baum","year":"2004","unstructured":"Baum C, von Kalle C, Staal FJ, Li Z, Fehse B, Schmidt M et al. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. Mol Ther 2004; 9: 5\u201313.","journal-title":"Mol Ther"},{"key":"BFleu2008219_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI30953","volume":"117","author":"M Cavazzana-Calvo","year":"2007","unstructured":"Cavazzana-Calvo M, Fischer A . Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest 2007; 117: 1456\u20131465.","journal-title":"J Clin Invest"},{"key":"BFleu2008219_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1517\/14712598.5.9.1175","volume":"5","author":"HB Gaspar","year":"2005","unstructured":"Gaspar HB, Thrasher AJ . Gene therapy for severe combined immunodeficiencies. Expert Opin Biol Ther 2005; 5: 1175\u20131182.","journal-title":"Expert Opin Biol Ther"},{"key":"BFleu2008219_CR8","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/sj.mt.6300297","volume":"15","author":"K Pike-Overzet","year":"2007","unstructured":"Pike-Overzet K, van der Burg M, Wagemaker G, van Dongen JJ, Staal FJ . New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol Ther 2007; 15: 1910\u20131916.","journal-title":"Mol Ther"},{"key":"BFleu2008219_CR9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1182\/blood-2002-07-2314","volume":"101","author":"C Baum","year":"2003","unstructured":"Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003; 101: 2099\u20132114.","journal-title":"Blood"},{"key":"BFleu2008219_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/leu.2008.118","volume":"22","author":"U Modlich","year":"2008","unstructured":"Modlich U, Schambach A, Brugman MH, Wicke DC, Knoess S, Li Z et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008; 22: 1519\u20131528.","journal-title":"Leukemia"},{"key":"BFleu2008219_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MOH.0b013e3281900f01","volume":"14","author":"C Baum","year":"2007","unstructured":"Baum C . Insertional mutagenesis in gene therapy and stem cell biology. Curr Opin Hematol 2007; 14: 337\u2013342.","journal-title":"Curr Opin Hematol"},{"key":"BFleu2008219_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/sj.leu.2404563","volume":"21","author":"K Pike-Overzet","year":"2007","unstructured":"Pike-Overzet K, de Ridder D, Weerkamp F, Baert MR, Verstegen MM, Brugman MH et al. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. Leukemia 2007; 21: 754\u2013763.","journal-title":"Leukemia"},{"key":"BFleu2008219_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.1091667","volume":"303","author":"UP Dave","year":"2004","unstructured":"Dave UP, Jenkins NA, Copeland NG . Gene therapy insertional mutagenesis insights. Science 2004; 303: 333.","journal-title":"Science"},{"key":"BFleu2008219_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/4401123a","volume":"440","author":"NB Woods","year":"2006","unstructured":"Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM . Gene therapy: therapeutic gene causing lymphoma. Nature 2006; 440: 1123.","journal-title":"Nature"},{"key":"BFleu2008219_CR15","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1038\/nature05218","volume":"443","author":"K Pike-Overzet","year":"2006","unstructured":"Pike-Overzet K, de Ridder D, Weerkamp F, Baert MR, Verstegen MM, Brugman MH et al. Gene therapy: is IL2RG oncogenic in T-cell development? Nature 2006; 443: E5; discussion E6\u20137.","journal-title":"Nature"},{"key":"BFleu2008219_CR16","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1038\/nature05219","volume":"443","author":"AJ Thrasher","year":"2006","unstructured":"Thrasher AJ, Gaspar HB, Baum C, Modlich U, Schambach A, Candotti F et al. Gene therapy: X-SCID transgene leukaemogenicity. Nature 2006; 443: E5\u2013E6; discussion E6\u20137.","journal-title":"Nature"},{"key":"BFleu2008219_CR17","doi-asserted-by":"publisher","first-page":"11730","DOI":"10.1073\/pnas.0603635103","volume":"103","author":"Y Shou","year":"2006","unstructured":"Shou Y, Ma Z, Lu T, Sorrentino BP . Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy. Proc Natl Acad Sci USA 2006; 103: 11730\u201311735.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008219_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687\u2013696.","journal-title":"Nat Biotechnol"},{"key":"BFleu2008219_CR19","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","volume":"108","author":"U Modlich","year":"2006","unstructured":"Modlich U, Bohne J, Schmidt M, von Kalle C, Knoss S, Schambach A et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545\u20132553.","journal-title":"Blood"},{"key":"BFleu2008219_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.1105063","volume":"308","author":"O Kustikova","year":"2005","unstructured":"Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005; 308: 1171\u20131174.","journal-title":"Science"},{"key":"BFleu2008219_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.1068893","volume":"296","author":"Z Li","year":"2002","unstructured":"Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.","journal-title":"Science"},{"key":"BFleu2008219_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.mt.6300393","volume":"16","author":"SI Thornhill","year":"2008","unstructured":"Thornhill SI, Schambach A, Howe SJ, Ulaganathan M, Grassman E, Williams D et al. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther 2008; 16: 590\u2013598.","journal-title":"Mol Ther"},{"key":"BFleu2008219_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.1083413","volume":"300","author":"X Wu","year":"2003","unstructured":"Wu X, Li Y, Crise B, Burgess SM . Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749\u20131751.","journal-title":"Science"},{"key":"BFleu2008219_CR24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1126\/science.1086238","volume":"300","author":"D Trono","year":"2003","unstructured":"Trono D . Virology. Picking the right spot. Science 2003; 300: 1670\u20131671.","journal-title":"Science"},{"key":"BFleu2008219_CR25","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2004-03-0798","volume":"105","author":"M De Palma","year":"2005","unstructured":"De Palma M, Montini E, de Sio FR, Benedicenti F, Gentile A, Medico E et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 2005; 105: 2307\u20132315.","journal-title":"Blood"},{"key":"BFleu2008219_CR26","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1371\/journal.pbio.0020234","volume":"2","author":"RS Mitchell","year":"2004","unstructured":"Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004; 2: E234.","journal-title":"PLoS Biol"},{"key":"BFleu2008219_CR27","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1371\/journal.ppat.0020060","volume":"2","author":"MK Lewinski","year":"2006","unstructured":"Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G et al. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2006; 2: e60.","journal-title":"PLoS Pathog"},{"key":"BFleu2008219_CR28","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1172\/JCI31659","volume":"117","author":"A Deichmann","year":"2007","unstructured":"Deichmann A, Hacein-Bey-Abina S, Schmidt M, Garrigue A, Brugman MH, Hu J et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007; 117: 2225\u20132232.","journal-title":"J Clin Invest"},{"key":"BFleu2008219_CR29","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1172\/JCI31661","volume":"117","author":"K Schwarzwaelder","year":"2007","unstructured":"Schwarzwaelder K, Howe SJ, Schmidt M, Brugman MH, Deichmann A, Glimm H et al. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 2007; 117: 2241\u20132249.","journal-title":"J Clin Invest"},{"key":"BFleu2008219_CR30","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1172\/JCI31666","volume":"117","author":"A Aiuti","year":"2007","unstructured":"Aiuti A, Cassani B, Andolfi G, Mirolo M, Biasco L, Recchia A et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J Clin Invest 2007; 117: 2233\u20132240.","journal-title":"J Clin Invest"},{"key":"BFleu2008219_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm844","volume":"9","author":"M Schmidt","year":"2003","unstructured":"Schmidt M, Carbonaro DA, Speckmann C, Wissler M, Bohnsack J, Elder M et al. Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nat Med 2003; 9: 463\u2013468.","journal-title":"Nat Med"},{"key":"BFleu2008219_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth1103","volume":"4","author":"M Schmidt","year":"2007","unstructured":"Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 2007; 4: 1051\u20131057.","journal-title":"Nat Methods"},{"key":"BFleu2008219_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1189\/jlb.0603287","volume":"75","author":"YY Ng","year":"2004","unstructured":"Ng YY, van Kessel B, Lokhorst HM, Baert MR, van den Burg CM, Bloem AC et al. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol 2004; 75: 314\u2013323.","journal-title":"J Leukoc Biol"},{"key":"BFleu2008219_CR34","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1073\/pnas.0409459102","volume":"102","author":"JF Zhong","year":"2005","unstructured":"Zhong JF, Zhao Y, Sutton S, Su A, Zhan Y, Zhu L et al. Gene expression profile of murine long-term reconstituting vs short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci USA 2005; 102: 2448\u20132453.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008219_CR35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1084\/jem.20042524","volume":"201","author":"WA Dik","year":"2005","unstructured":"Dik WA, Pike-Overzet K, Weerkamp F, de Ridder D, de Haas EF, Baert MR et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 2005; 201: 1715\u20131723.","journal-title":"J Exp Med"},{"key":"BFleu2008219_CR36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.gt.3302270","volume":"11","author":"B Fehse","year":"2004","unstructured":"Fehse B, Kustikova OS, Bubenheim M, Baum C . Pois(s)on\u2014it's a question of dose. Gene Ther 2004; 11: 879\u2013881.","journal-title":"Gene Ther"},{"key":"BFleu2008219_CR37","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1182\/blood-2003-05-1424","volume":"102","author":"OS Kustikova","year":"2003","unstructured":"Kustikova OS, Wahlers A, Kuhlcke K, Stahle B, Zander AR, Baum C et al. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 2003; 102: 3934\u20133937.","journal-title":"Blood"},{"key":"BFleu2008219_CR38","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1182\/blood-2004-11-4535","volume":"105","author":"U Modlich","year":"2005","unstructured":"Modlich U, Kustikova OS, Schmidt M, Rudolph C, Meyer J, Li Z et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 2005; 105: 4235\u20134246.","journal-title":"Blood"},{"key":"BFleu2008219_CR39","first-page":"53","volume":"324","author":"M Ito","year":"2008","unstructured":"Ito M, Kobayashi K, Nakahata T . NOD\/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008; 324: 53\u201376.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFleu2008219_CR40","first-page":"25","volume":"324","author":"T Pearson","year":"2008","unstructured":"Pearson T, Greiner DL, Shultz LD . Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol 2008; 324: 25\u201351.","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008219","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:06:40Z","timestamp":1648724800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,4]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["BFleu2008219"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.219","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,4]]},"assertion":[{"value":"1 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}